Richard R. Kerr
For this urologist, three careers have been gratifying
He’s a urologist, but Daniel Shames, MD, has actually had three careers: practicing urologist, FDA official, and pharmaceutical industry consultant.
Breast cancer drug may play role in bladder cancer
Mayo Clinic researchers have found amplification of HER2, a known driver of some breast cancers, in micropapillary urothelial carcinoma and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors.
Nevada shooting update: Experts question surgery link
There is no evidence that vasectomy leads to significant health problems, making it unlikely that the Urology Nevada patient who took the life of one urologist and injured another was suffering from the effects of “botched” surgery, say two urologists who are experts in vasectomy.
ICSI outcomes similar with fresh, frozen sperm
In men with nonobstructive azoospermia, frozen and fresh testicular sperm offer similar fertilization and pregnancy rates, according to the authors of a meta-analysis who say it is the first such study to specifically address the fresh-versus-frozen debate in this population.
Robotic partial nephrectomy: Renal function loss low in CKD patients
Patients with chronic kidney disease who undergo robot-assisted partial nephrectomy for kidney cancer have minimal loss of renal function—a smaller amount even than patients with normal kidney function, according to researchers at Henry Ford Hospital in Detroit, who say their study is the largest of its kind.
Tool may predict prostate Ca overdiagnosis risk
Researchers at Fred Hutchinson Cancer Research Center and the University of Washington in Seattle have developed a personalized tool that they say can predict the likelihood of prostate cancer overdiagnosis.
Death, incidence rates of prostate cancer, other GU cancers drop
Both the death rate and incidence rate for prostate cancer continues to decline, according to the latest round of statistics from leading U.S. cancer groups.
Urology ranks second in e-prescribing adoption
About two-thirds of urologists own electronic prescribing systems, placing urology second among specialties in e-prescribing adoption, according to a study that tracked adoption rates between 2007 and 2010.
Coverage expands for prostate cancer test, PTNS
Insurance coverage has expanded for an epigenetic test for prostate cancer and percutaneous tibial nerve stimulation (PTNS) for the treatment of overactive bladder (OAB).
Inflammation in biopsies may indicate lower prostate cancer risk
Signs of inflammation in a man’s prostate biopsy may indicate that he has a reduced risk of subsequently being diagnosed with prostate cancer in a future biopsy, according to the authors of a recently published study.